6926.TWO Shine-On BioMedical Co.,Ltd.

Healthcare Biotechnology Taiwan OTC Exchange
55.50 TWD
Close of Nov 6, 2026
53.80 73.60
Market cap
TWD 2.76B
P/E
-
P/B
3.75x
ROE
-12.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6926.TWO undervalued?

Graham number

The Graham number of Shine-On BioMedical Co.,Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shine-On BioMedical Co.,Ltd. fundamental analysis

No fundamental analysis for Shine-On BioMedical Co.,Ltd. yet.

Shine-On BioMedical Co.,Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd. was founded in 2011 and is based in Taichung, Taiwan.

Full company profile